Craneware plc (LON:CRW)‘s stock had its “buy” rating reissued by equities research analysts at Peel Hunt in a research report issued on Tuesday. They currently have a GBX 1,335 ($16.11) price objective on the stock. Peel Hunt’s price objective would indicate a potential downside of 0.19% from the company’s previous close.
Shares of Craneware plc (LON:CRW) opened at 1339.80 on Tuesday. Craneware plc has a 52 week low of GBX 730.00 and a 52 week high of GBX 1,379.70. The stock has a 50 day moving average of GBX 1,240.20 and a 200-day moving average of GBX 1,140.30. The company’s market capitalization is GBX 359.74 million.
About Craneware plc
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.